- Koesbandono

- Koesbandono


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in Medicina
Verified
Journal Article
Open access
PDF file
-K- Koesbandono
- Koesbandono
ALAntonia Anna Lukito
Antonia Anna Lukito
RMRusli Muljadi
Rusli Muljadi
MYMira Yuniarti
Mira Yuniarti
NSNyoman Aditya Sindunata
Nyoman Aditya Sindunata
GOGilbert Sterling Octavius
Gilbert Sterling Octavius
Background and Objectives: Myocardial bridging (MB) is still not yet considered a significant finding in Indonesia both radiographically and clinically. Hence, this article aims to assess the prevalence of MB using multi-detector computed tomography (MDCT) and look at factors contributing to stenosis amongst patients with MB. Materials and Methods: This study is cross-sectional in a single centre, with consecutive sampling, looking at all patients who underwent a multi-detector computed tomography (MDCT) scan from February 2021 until February 2023. GraphPad Prism version 9.0.0 for Windows (GraphPad Software, Boston, MA, USA) was used to analyse the results. Results: There are 1029 patients with an MB, yielding a prevalence of 44.3% (95%CI 42.3–46.4). The left anterior descending vessel is the most commonly implicated, with 99.6%. Among those with stenosis, the middle portion of the bridging vessel is the most common site of stenosis (n = 269), followed by the proximal portion (n = 237). The severity of stenosis is more often moderate, with 30–50% (n = 238). Females (odds ratio [OR] of 1.8, 95%CI 1.4–2.3; p-value < 0.0001), older age (t-value 5.6, p-value < 0.0001), symptomatic patients (OR 1.4, 95% CI 1.1–1.9; p-value = 0.013), and higher mean coronary artery calcium score (t-value 11.3, p-value < 0.0001) are more likely to have stenosis. The degree of stenosis is significantly higher in the proximal stenosis group than in the middle stenosis group (t-value 27, p-value < 0.0001). Conclusions: Our research demonstrates that MB may prevent atheromatosis of the coronary segment distal to the MB and predispose the development of atherosclerosis in the section proximal to the bridge.

5 July 2024 in Egyptian Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
-K- Koesbandono
- Koesbandono
PSPrijo Sidipratomo
Prijo Sidipratomo
RURaditya Utomo
Raditya Utomo
CTChristiano Tansol
Christiano Tansol
YKYohanes Chandra Kurniawan
Yohanes Chandra Kurniawan
Background: Acute spontaneous bleeding from renal angiomyolipoma (AML) is one of the causes of Wunderlich syndrome, a rare and potentially fatal clinical condition. Clinical deterioration will occur if there is a delay in urgent management. There are several management options for renal angiomyolipoma rupture. However, until now little is known about the case of recanalization from post-coil embolization of renal angiomyolipoma. There is no guideline about embolization technique for the management of recurrent bleeding after embolization or coil recanalization of renal angiomyolipoma. Case presentation: A 55-year-old male has Wunderlich syndrome caused by recurrent bleeding of giant AML of the left renal due to coil recanalization compounded by a pseudoaneurysm and other bleeding site in bilateral giant renal angiomyolipoma which is showed by contrast-enhanced abdominal computed tomography scan. The patient underwent urgent transarterial embolization and some blood transfusion. Clinical improvement occurred and the patient discharged several days later. Conclusions: Embolization for spontaneous bleeding or rebleeding of renal pseudoaneurysms may become the first choice of treatment in bilateral multiple renal angiomyolipoma rather than other managements which are available to preserve renal function.

25 October 2026 in Egyptian Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
-K- Koesbandono
- Koesbandono
MAMakbul Aman
Makbul Aman
BMBachtiar Murtala
Bachtiar Murtala
GOGilbert Sterling Octavius
Gilbert Sterling Octavius
Introduction: Cognitive impairment is common in chronic kidney disease (CKD), particularly among patients with advanced disease and dialysis dependence, yet the underlying mechanisms remain incompletely understood. Proton magnetic resonance spectroscopy ( 1 H-MRS) enables non-invasive assessment of cerebral metabolites and may provide insight into metabolic pathways associated with cognitive dysfunction. This systematic review evaluated the relationship between brain metabolic alterations detected by 1 H-MRS and cognitive impairment in CKD. Methods: A PRISMA 2020-compliant systematic review was conducted using the Cochrane Library, PubMed, ScienceDirect, Google Scholar, and supplementary backward and forward citation-searching methods through May 2026. Observational studies reporting both 1 H-MRS brain metabolite measurements and standardized cognitive assessments in CKD patients were included. Methodological quality was evaluated using the Newcastle–Ottawa Scale. Results: Five studies involving 231 CKD patients met inclusion criteria. Cognitive impairment was reported across all studies, affecting intelligence, memory, attention, executive function, and processing speed. Recurrent directional metabolic abnormalities were reported in advanced CKD and dialysis populations, including reduced creatine concentrations, decreased N-acetylaspartate-to-creatine (NAA/Cr) ratios, and increased myo-inositol-to-creatine (mI/Cr) ratios, although substantial heterogeneity in populations, brain regions, acquisition protocols, and quantification methods limited direct quantitative comparability. An isolated inverse correlation between mI/Cr and performance IQ ( r =  − 0.895) was reported in a single pediatric cohort but has not been independently replicated and should therefore be considered hypothesis-generating. Importantly, some studies demonstrated metabolic abnormalities without corresponding metabolite–cognition correlations, suggesting that additional vascular, inflammatory, or uremic mechanisms may contribute to cognitive decline. Overall study quality ranged from poor to good. Conclusion: Cerebral metabolic abnormalities have been reported in advanced CKD and dialysis populations, frequently alongside cognitive impairment; however, direct metabolite–cognition associations remain inconsistent and insufficiently replicated. Current evidence does not establish causality or support routine clinical use of MRS-based biomarkers.